Dementia News and Research

Latest Dementia News and Research

Pericyte cells become key players in shaping blood flow in the brain

Cells in the brain called pericytes that have not been high on the list of targets for treating diseases like Alzheimer's may play a more crucial role in the development of neurodegenerative diseases than has been realized.

18 Nov 2010

OSEO awards €10.4 million to DIPPAL project targeting Alzheimer's disease

The biotech companies PHARNEXT and BIOSYSTEMS INTERNATIONAL, the Bordeaux Hospital where CMRR is located, the university Bordeaux Segalen and Inserm (the center U897 "Epidemiology and Biostatistics") have joined forces to carry out the DIPPAL2i project. This innovative research and industrial development project is targeting Alzheimer's disease (AD) and has attracted significant financial support from OSEO (the French state innovation agency).

18 Nov 2010

New findings identify Sortilin as a potential therapeutic site to alter PGRN pathology in dementia

Frontotemporal lobar degeneration (FTLD) refers to a group of disorders associated with degeneration of the frontal and temporal lobes of the brain. Symptoms include dementia, aphasia, and semantic disorders.

18 Nov 2010

Researchers find clue behind dementia development

Researchers at the Mayo Clinic campus in Florida have found a clue as to how some people develop a form of dementia that affects the brain areas associated with personality, behavior, and language.

18 Nov 2010

Cigarette smoke, automobile exhaust and french fries increase risk of developing Alzheimer's disease

There is growing evidence that exposure to a group of chemicals known as type-2 alkenes -- which are found in the smoke inhaled from cigarettes, the exhaust of automobiles and even in French fries - can increase the chances of developing Alzheimer's disease and other neurological conditions such as Parkinson's disease.

18 Nov 2010

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.

18 Nov 2010

Survey on palliative care for patients with dementia

A new national survey conducted by researchers from Indiana University and the Regenstrief Institute has found that while palliative care may be available for those with dementia, there are significant barriers to providing or receiving services to relieve the pain, eating difficulties and other symptoms associated with dementia.

17 Nov 2010

Adult children of mothers with Alzheimer's at increased risk

A family history of Alzheimer's disease significantly increases the risk for developing this disorder, but a new study in Biological Psychiatry suggests that which of your parents has the disease is very important.

17 Nov 2010

New educational campaign provides information to Alzheimer's caregivers

More than five million people in the United States (U.S.) have Alzheimer's disease (AD), a progressive and devastating condition that also impacts millions of more people who love and care for these patients. Last year in the U.S., the 11 million unpaid caregivers for patients with Alzheimer's or another dementia provided 12.5 billion hours of care.

17 Nov 2010

Structural imaging techniques can help identify risk for developing Alzheimer's disease

New results from a study by neuroscientists at Rush University Medical Center suggest that people at risk of developing Alzheimer's disease exhibit a specific structural change in the brain that can be visualized by brain imaging. The findings may help identify those who would most benefit from early intervention.

17 Nov 2010

Risk reduction of 20 ailments with regular exercise: Review

In a review article researchers have concluded that regular exercise cuts the risk of more than 20 illnesses. Some of these include colon cancer, heart disease, diabetes, osteoporosis and stroke said the study published in the International Journal of Clinical Practice.

16 Nov 2010

Synexus to develop effective clinical trials for Mild cognitive impairment

Mild cognitive impairment (MCI) is under the pharma' spotlight as the number of clinical trials currently underway has increased significantly during the past 12 months and the search for treatments that will prevent the progression of MCI to dementia continues. Synexus has teamed up with dementia expert, Dr Roger Bullock, to develop more effective clinical trials for this field.

From AES - Accelerated Enrollment Solutions 16 Nov 2010

Size of hippocampus may be linked to early dementia

The size of the part of the brain known as the hippocampus may be linked to future dementia, reveals a thesis from the University of Gothenburg, Sweden.

16 Nov 2010

Handwriting problems in autistic children likely to continue into teenage years: Study

A new study suggests that the handwriting problems that affect children with autism are likely to continue into their teenage years.

16 Nov 2010

Regular exercise could reduce risk of developing physical, mental health conditions

People who take regular exercise could reduce their risk of developing around two dozen physical and mental health conditions including some cancers and dementia and slow down how quickly their body deteriorates as they age.

15 Nov 2010

Journal of Alzheimer's Disease highlights latest scientific studies of AD

A supplement to the Journal of Alzheimer's Disease on "Anesthetics and Alzheimer's Disease" provides the platform to bring the latest scientific studies to the AD research and clinical communities.

15 Nov 2010

30 seconds to predict possibility of Alzheimer’s disease

It could take a mere 30 seconds to spot signs of Alzheimer’s disease in 40 year-olds in the near future say scientists who are developing a new diagnostic test. Usually Alzheimer’s disease is detected much later in life after the symptoms begin to appear.

14 Nov 2010

Eight students to receive Hartford Doctoral Fellowship in geriatric social work

Eight outstanding students have been chosen as the newest recipients of the prestigious Hartford Doctoral Fellowship in geriatric social work. The program is funded by the John A. Hartford Foundation, administered by The Gerontological Society of America, and directed by James Lubben, DSW, MPH.

12 Nov 2010

Seven stages of Alzheimer's disease

Now, during Alzheimer's Awareness month, is an important time to recognize Alzheimer's and its symptoms. Alzheimer's is the most common form of dementia that has a higher risk factor with increasing age. It is a progressive disease that worsens with time. Besides the most common early symptom of Alzheimer's, which is difficulty remembering new information, there are seven stages of Alzheimer's, according to the Alzheimer's Association. It is important to track the different stages to have an understanding and be an efficient caregiver to a loved one.

12 Nov 2010

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

Forest Laboratories, Inc. announced that Forest Laboratories Holdings Limited, its wholly owned subsidiary, has entered into a definitive collaboration and distribution agreement for Bystolic® (nebivolol) and Savella® (milnacipran HCl) in Canada with Janssen Pharmaceutica, NV and Janssen Pharmaceutical respectively, on behalf of Janssen Inc., which will market the products in Canada.

12 Nov 2010

Dementia News and Research

Latest Dementia News and Research

Pericyte cells become key players in shaping blood flow in the brain

OSEO awards €10.4 million to DIPPAL project targeting Alzheimer's disease

New findings identify Sortilin as a potential therapeutic site to alter PGRN pathology in dementia

Researchers find clue behind dementia development

Cigarette smoke, automobile exhaust and french fries increase risk of developing Alzheimer's disease

Neuralstem files NSI-189 IND with FDA for Phase I safety trials for major depression

Survey on palliative care for patients with dementia

Adult children of mothers with Alzheimer's at increased risk

New educational campaign provides information to Alzheimer's caregivers

Structural imaging techniques can help identify risk for developing Alzheimer's disease

Risk reduction of 20 ailments with regular exercise: Review

Synexus to develop effective clinical trials for Mild cognitive impairment

Size of hippocampus may be linked to early dementia

Handwriting problems in autistic children likely to continue into teenage years: Study

Regular exercise could reduce risk of developing physical, mental health conditions

Journal of Alzheimer's Disease highlights latest scientific studies of AD

30 seconds to predict possibility of Alzheimer’s disease

Eight students to receive Hartford Doctoral Fellowship in geriatric social work

Seven stages of Alzheimer's disease

Forest enters commercialization collaboration with Janssen for Bystolic and Savella in Canada

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Dementia News and Research

Latest Dementia News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in